CTC Alternative Strategies’s Elevance Health ELV Stock Holding History

CTC Alternative Strategies’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,380	Closed	-$537K	–	125
2025 Q2	$537K	Buy	+1,380	New	+$555K	0.47%	64
2024 Q3	–	Sell	-399	Closed	-$216K	–	110
2024 Q2	$216K	Buy	+399	New	+$211K	0.09%	170
2024 Q1	–	Sell	-900	Closed	-$424K	–	149
2023 Q4	$424K	Buy	+900	New	+$416K	0.88%	24
2023 Q3	–	Sell	-500	Closed	-$222K	–	112
2023 Q2	$222K	Buy	+500	New	+$231K	0.28%	114
2014 Q4	–	Sell	-2,500	Closed	-$299K	–	144
2014 Q3	$299K	Buy	2,500 +600	+32%	+$68.8K	0.55%	27
2014 Q2	$204K	Buy	+1,900	New	+$196K	0.17%	182

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

CTC Alternative Strategies's ELV Position: Q3 2025 in Review

CTC Alternative Strategies sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,380 shares — an estimated $537K sold.

CTC Alternative Strategies first reported a position in ELV in Q2 2014 and held it in 6 quarters. The position peaked at $537K in Q2 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

CTC Alternative Strategies reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
CTC Alternative Strategies sold 1,380 Elevance Health shares in Q3 2025, an estimated $537K.
CTC Alternative Strategies first reported a position in Elevance Health in Q2 2014 and held it in 6 quarters.
CTC Alternative Strategies's Elevance Health position peaked at $537K in Q2 2025.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on CTC Alternative Strategies's 13F filing for Q3 2025, filed 15 Dec 2025.